AI/ML Innovations Announces Listing on Frankfurt Stock Exchange - TheNewswire.ca
August 20, 2021 – TheNewswire - AI/ML Innovations Inc. (CSE:AIML) (CNSX:AIML.CN) (OTC:AIMLF) (“AIML” or the “Company”), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that is now listed for trading on the Frankfurt Stock Exchange.
AIML is now listed on the Frankfurt Stock Exchange (also known as the Deutsche Boerse AG), one of the largest stock exchanges in the world, under WKN: A2QMBE and the symbol: 42FB. The Company’s shares continue to be listed on the Canadian Securities Exchange under the symbol: AIML, as well as continuing to trade on the OTCQB under the symbol: AIMLF
The Frankfurt listing will increase the visibility of the Company amongst European investors and will make it easier for both institutional and retail investors across Europe to participate in the market for AIML shares.
"We are very pleased to improve the access to our shares for our growing followers across the European Union", said Tim Daniels, Chairman of AI/ML Innovations Inc. "As we expand our corporate footprint into Europe by way of our investment in France-based Tech2Heal, we are seeing a corresponding increase in interest from European based investors who will benefit from our Frankfurt listing."
Additionally, the Company announces that it has entered an agreement with the Swiss based advisor, Pro Return AG to provide AIML with capital markets consulting services internationally. Pro Return shall focus on international markets with the goal of introductions to institutional investors in order to finance the Company, with consulting services to include a review of the Company’s business plans, corporate presentations and general corporate development materials. The contract is set to run for a 17-month period commencing August 1, 2021 through December 31, 2022 at a cost of €23,530 per month. Pro Return AG is arms-length from AIML.
About AI/ML Innovations Inc .
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge, Tech2Health and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company’s stakeholders. AI/ML’s shares are traded on the Canadian Securities Exchange under the symbol "AIML" and on the OTCQB Venture Market under “AIMLF”.
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
For more information about AI/ML Innovations :
For detailed information please see AI/ML's website at https://aiml-innovations.com/
or the Company's filed documents at www.sedar.com.
For further information: Blake Fallis at (778) 405-0882 or [email protected]
Investor slidedeck: https://aiml-innovations.com/wp-content/uploads/2021/01/AIML-mini-1-21.pdf
Corporate video: https://www.youtube.com/watch?v=k2QSjo7clXcfeature=youtu.be
Official YouTube Channel: https://www.youtube.com/channel/UCCfOj2P_Fu3TOK6Jl1G9vEQ
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Cautionary and Forward-Looking Statements
Certain information in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including but not limited to, the uncertainty of competition by other industry players, the impact of general economic conditions, industry conditions, dependence upon regulatory approvals and the ability to raise additional capital as may be needed in the future. Readers are cautioned that the assumptions used in preparing such information, although considered reasonable at the time of preparation, may prove imprecise and undue reliance should not be placed on forward-looking statements. Forward-looking statements in this press release are expressly qualified by this cautionary statement.
The forward-looking statements in this press release are made as of the date of this press release, and the Company undertakes no obligations to update publicly or to revise any of the included forward-looking statements, whether because of new information, future events or otherwise, except as expressly required by applicable securities law.